These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36224112)

  • 1. Structure-Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor.
    Wang S; Zhu A; Paudel S; Jang CG; Lee YS; Kim KM
    Biomol Ther (Seoul); 2023 Mar; 31(2):176-182. PubMed ID: 36224112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists.
    Marcher-Rørsted E; Halberstadt AL; Klein AK; Chatha M; Jademyr S; Jensen AA; Kristensen JL
    ACS Chem Neurosci; 2020 May; 11(9):1238-1244. PubMed ID: 32212672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues.
    Nichols DE; Sassano MF; Halberstadt AL; Klein LM; Brandt SD; Elliott SP; Fiedler WJ
    ACS Chem Neurosci; 2015 Jul; 6(7):1165-75. PubMed ID: 25547199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
    Smith DA; Bailey JM; Williams D; Fantegrossi WE
    J Pharmacol Exp Ther; 2014 Dec; 351(3):485-91. PubMed ID: 25271256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 2A Receptor (5-HT
    Pottie E; Kupriyanova OV; Brandt AL; Laprairie RB; Shevyrin VA; Stove CP
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):479-487. PubMed ID: 33860178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
    Johnson MP; Loncharich RJ; Baez M; Nelson DL
    Mol Pharmacol; 1994 Feb; 45(2):277-86. PubMed ID: 8114677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological characterization of 2-(4-chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl derivatives as dopamine receptor ligands.
    Claudi F; Giorgioni G; Di Stefano A; Abbracchio MP; Paoletti AM; Balduini W
    J Med Chem; 1992 Nov; 35(23):4408-14. PubMed ID: 1360027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
    Van Vunakis H; Farrow JT; Gjika HB; Levine L
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1483-7. PubMed ID: 5283939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Functional Role of Phenethylamine Derivatives in Inhibiting Dopamine Reuptake: Structure-Activity Relationship.
    Kundu D; Zhu A; Kim E; Paudel S; Jang CG; Lee YS; Kim KM
    Biomol Ther (Seoul); 2023 Jan; 31(1):108-115. PubMed ID: 36098044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
    Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
    J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines.
    Toro-Sazo M; Brea J; Loza MI; Cimadevila M; Cassels BK
    PLoS One; 2019; 14(1):e0209804. PubMed ID: 30629611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Bivalent 5-HT
    Soto CA; Shashack MJ; Fox RG; Bubar MJ; Rice KC; Watson CS; Cunningham KA; Gilbertson SR; Anastasio NC
    ACS Chem Neurosci; 2018 Mar; 9(3):514-521. PubMed ID: 29111677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.
    Kurrasch-Orbaugh DM; Watts VJ; Barker EL; Nichols DE
    J Pharmacol Exp Ther; 2003 Jan; 304(1):229-37. PubMed ID: 12490596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships for substrates and inhibitors of pineal 5-hydroxytryptamine-N-acetyltransferase: preliminary studies.
    Shen S; Brémont B; Serraz I; Andrieux J; Poncet A; Mathé-Allainmat M; Chanut E; Trouvin JH; Langlois M
    Eur J Pharmacol; 1996 Jun; 307(2):133-40. PubMed ID: 8832214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
    Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines.
    Martin LL; Roland DM; Neale RF; Wood PL
    Eur J Pharmacol; 1986 Dec; 132(1):53-5. PubMed ID: 3816964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.